Talk Now: FDA Finalizes Guidance On Pre-Market Communications
This article was originally published in The Gray Sheet
Executive Summary
The guidance, which is very similar to a proposed version from last year, updates the interactive review program, and describes three relatively new points of communication between FDA and a device sponsor during the review process.